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Abstract
The main diagnostic tool for toxic adenomas (TA) is radionuclide imaging indicated in patients with evidence of thyroid nodules 
in combination with thyrotoxic syndrome. Thyroid ultrasound and fine-needle aspiration biopsy (FNAB) are widely used for 
the evaluation of thyroid masses. There is no literature data concerning the utility of FNAB and related tests for the diagnosis 
of hyperfunctioning thyroid nodules. The purpose of this study is to determine the levels of free thyroxine (FT4) in the needle 
washout after FNAB of hot thyroid nodules. The results of our study show that the FT4 levels in needle washout from TA were 
significantly higher than the surrounding parenchyma and correlated with the hormonal changes in patients with thyroid hy-
perfunctioning nodules. Further studies on a large number of patients are needed to refine the diagnostic value of this method 
and evaluate its importance in quantitative risk assessment of thyroid autonomy.
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Background
Thyroid autonomy is a common finding in iodine-deficient are-
as where it accounts for 60% of the cases with thyrotoxicosis (toxic 
adenoma — 10%; toxic multinodular goiter — 50%) [1, 2]. The 
main diagnostic tool to ascertain toxic adenomas (TA) is ra-
dionuclide imaging which is indicated in patients with clinical 
or ultrasound (US) evidence of thyroid nodules in combination 
with thyrotoxic syndrome. TA are most commonly diagnosed 
due to clinically overt thyrotoxicosis [3]. Thyroid ultrasound and 
fine-needle aspiration biopsy (FNAB) are widely used for the evalu-
ation of thyroid masses [4]. There is no literature data on the utility 
of FNAB and related tests for the diagnosis of hyperfunctioning 
thyroid nodules.
Aim
To determine the levels of free thyroxine (FT4) in the needle 
washout after FNAB of hot thyroid nodules.
Material and methods
Nineteen patients (mean age 51.79 ± 2.97; from 29 to 71 years) 
were included in the study. Male/Female ratio was 1: 3.75 (Table 1). 
All patients had hormonal evidence of thyrotoxicosis (mainly subclini-
cal) and hyperfunctioning nodules detected on thyroid radionuclide 
scan. Outpatients were referred to an endocrinologist for thyroid 
gland assessment due to the presence of palpable thyroid mass or 
changes in thyroid hormones levels. Medical history at the time of 
primary evaluation did not reveal concomitant autoimmune thyroid 
diseases, previous treatment with antithyroid drugs, levothyroxine, 
iodine supplements or radioiodine treatment. According to the ra-
dionuclide imaging findings, nodules were classified as decompen-
sated (hyperfunctioning nodules with suppression of extranodular 
gland), subcompensated (increased uptake in the nodule with slight 
suppression of extranodular parenchyma) and compensated (no-
dules with increased uptake compared with adjacent tissue without 
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suppression of extranodular thyroid tissue). Ultrasound (US) exami-
nation of the neck region was performed by one investigator using 
linear transducer with modulated 10–18 MHz frequency — LA435 
(Esaote MyLab 25 Gold). US guided FNAB of the described nodular 
formations was conducted and a sample for cytological examination 
was prepared. The needle was washed out after the dispersal of the 
punctate onto a slide with 1 ml saline and levels of free thyroxine 
(FT4) in the washout were measured by electro-chemiluminescence 
immunoassay (ECLIA) (Roche Elecsys 2010 analyzer). An additional 
washout sample from the surrounding parenchyma was prepared 
according to the method described above. Serum levels of thyroid 
stimulating hormone TSH (RR 0.27–4.20 μIU/ml); free thyroxine FT4 
(RR 10–25 pmol/l); free triiodothyronine FT3 (RR 2.8–7.1 pmol/l) were 
also determined as blood samples obtained before FNAB. Thyroid 
scintigraphy was performed using 99mTc-pertechnetate 2–5 mCi, 
given as an intravenous injection. Patient preparation included exclu-
sion of medications that are known to affect thyroid uptake. Thyroid 
scan was performed as a planar scan on a gamma camera ADAX 
Vertex with low energy general purpose collimator, planar acquisi-
tion, 512 x 512 matrix for 5 minutes or 300 000 counts. Patients with 
preexisting autoimmune thyroid disorders were excluded from the 
study. All patients signed an informed consent form to participate 
in the study. For statistical analysis exact Fisher test and correlation 
analysis were applied.
Results
The results from cytological examination of the specimen from 
all patients demonstrated benign thyroid nodules (Figure 1).
The analysis of the data showed significantly higher levels of 
FT4 in the washout from the nodules compared with those from 
the surrounding thyroid tissue (Figure 2).
Considering that hormonal changes in patients with toxic 
thyroid nodules result from excessive hormonal production from 
the adenoma, a correlation between the levels of FT4 in the 
washout samples and serum levels of thyroid hormones and TSH 
was presumed. The analysis found statistically significant correla-
Table 1. Characteristics of the studied patients
Patients n %
Gender
Female 15 78.95
Male 4 21.05
Age (years)
Mean 51.79 ± 2.97
Range 29–71
Serum levels of:
TSH 0.16 ± 0.03
FT4 19.81 ± 1.28
FT3 6.57 ± 0.37
Volume of the nodule [ml] 2.70 ± 0.39
Volume of the thyroid gland [ml] 13.56 ± 0.61
Radionuclide scan
Compensated 1 5.26
Subcompensated 13 68.42
Decompensated 5 26.32
Figure 1. A case of 52-year-old female presenting with hot thyroid 
nodule on radionuclide scan B and C. US features: a dominant solid 
isoechoic with peripheral and intranodular vascularization nodule sized 
23/14/27MM: A. FT4 needle wash-out from the nodule = 137 pmol/l. 
FT4 needle washout from the surrounding parenchyma = 1.48 pmol/l. 
Cytological result: Bethesda category 2 (benign lesion)
A
C
B
Figure 2. Mean FT4 in the needle washout from the nodule compared 
to surrounding parenchyma
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tion between FT4 in the washout and serum FT4 and a negative 
correlation with the TSH concentrations (Figure 3). No correlation 
with serum levels of FT3 was established.
Correlation between the levels of FT4 in washout from thyroid 
parenchyma and serum FT4 (r = 0.53, P = 0.021) and FT3 (r = 0.47; 
P = 0.042) was found.
The mean values of FT4 in the washout from the decompen-
sated TA were significantly higher (Table 2).
It is known that the severity of hormonal changes in patients with 
TA is related to the size of the TA [5]. In the present study a similar 
correlation between the nodule volume and serum TSH, FT3 and 
FT4 was found. However, a correlation between the levels of FT4 
in fine needle washout and the volume of the TA and the thyroid 
volume was not ascertained.
Discussion
Currently, the diagnosis of toxic adenoma is based on three 
main criteria: clinical and/or hormonal evidence of thyrotoxicosis, 
palpable or ultrasonographic finding of thyroid mass and increased 
radionuclide uptake in the suspected nodule along with suppressed 
activity in the remainder of the thyroid [3]. FNAB is not a routine 
diagnostic method of toxic adenomas due to the low risk of malig-
nancy, but provides valuable information on the benign nature of the 
formations especially in the absence of radionuclide imaging at the 
time of evaluation. Long-term studies of patients with TA have shown 
that the natural course of the disease is slow and requires years or 
decades to develop thyrotoxic syndrome. In a study of Sandrock 
et al. authors reported 4.1% annual incidence of thyrotoxicosis in 
a group of 375 untreated euthyroid patients with TA [6].
Measurement of bioactive substances in needle washout after 
FNAB is widely used in clinical thyroidology. At present, the most 
extensive research has been made on the accuracy of thyroglobulin 
in needle washout which has shown the highest sensitivity and 
specificity in diagnosing of metastatic lymph nodes in patients with 
differentiated thyroid carcinoma [7]. There are also data regard-
ing the diagnostic value of parathyroid hormone in patients with 
adenomas of the parathyroid glands [8] and calcitonin in medul-
lary carcinomas [9]. The review of the literature does not provide 
studies focused on measurement of hormonal parameters from the 
needle washout after FNAB of hyperfunctioning thyroid nodules. 
In the current study we analyzed the data of 19 patients with 
TA in whom the FT4 level from needle washout is assessed. The 
samples were prepared following the methodology applied for 
thyroglobulin measurement in fine needle washout from metastatic 
lymph nodes [10]. The results showed significantly higher levels of 
FT4 in washout from the nodules compared with the surrounding 
thyroid parenchyma. These findings are consistent with the evi-
dence of focal hormone oversecretion from the adenoma and the 
relative suppression of the intact thyroid tissue. The established 
correlation between FT4 in washout from TA and serum levels of 
FT4 and the negative correlation with TSH confirms the relation 
between TA and thyroid function tests and can provide useful 
data on the activity of overactive thyroid tissue. Hot nodules do 
not have the same functional activity and if the serum hormone 
levels are directly related to the volume of the nodule, the hormonal 
production from a similar volume is different. We did not establish 
a correlation between the thyroid adenoma volume and the level 
of FT4 in the washout which is in accordance with this standpoint. 
Despite the limited number of cases at this phase of the study, 
significantly higher mean levels of FT4 in decompensated nod-
ules were found compared with subcompensated and compen-
sated adenomas. It can be assumed that measurement of FT4 in 
washout from TA can provide circumstantial evidence of nodule 
hyperfunction and justify further tests to verify the diagnosis. 
It is stated in the current guidelines that the clinical approach to the 
diagnosis and treatment of thyroid nodules should be determined 
by the results of ultrasound examination in combination with the 
cytological result after FNAB [4]. The measurement of the FT4 
in needle washout after FNAB provides additional information to 
the diagnostic approach. 
Figure 3. Correlation between FT4 needle washout form TA and 
serum TSH and FT4
Table 2. FT4 needle washout form TA and from surrounding parenchyma in compensated and decompensated nodules
Compensated/subcompensated decompensated P
FT4 in needle washout from TA 40.62 ± 13.29 145.25 ± 45.62 = 0.01
FT4 in needle washout from parenchyma 5.76 ± 4.08 17.21 ± 12.63 > 0.05
Mean FT4 in nodule/FT4 in parenchyma ratio 37.58 61.18 > 0.05
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Conclusion
The results of our study show that the FT4 levels in needle 
wash-out from TA were significantly higher than the surround-
ing parenchyma and correlated with the hormonal changes in 
patients with thyroid hyperfunctioning nodules. Further studies on 
a large number of patients are needed to refine the diagnostic 
value of this method. Based on our preliminary data, we consider 
FT4 in washout from TA a potential diagnostic tool for the early 
diagnosis of toxic thyroid adenoma.
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